Xeris Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $445k | 77k | 5.80 |
| 2025-03-31 | $449k | 82k | 5.49 |
| 2024-12-31 | $296k | 87k | 3.39 |
| 2024-09-30 | $169k | 59k | 2.85 |
| 2024-06-30 | $186k | 83k | 2.25 |
| 2023-12-31 | $167k | 71k | 2.35 |
| 2023-09-30 | $133k | 71k | 1.86 |
| 2023-03-31 | $116k | 71k | 1.63 |
| 2022-12-31 | $34k | 26k | 1.33 |
| 2022-09-30 | $111k | 71k | 1.57 |
| 2022-06-30 | $109k | 71k | 1.54 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors